当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析 - 现金流量表

云南白药

(000538)

  

流通市值:901.57亿  总市值:907.42亿
流通股本:17.85亿   总股本:17.97亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金29,925,903,156.6320,702,033,007.459,660,075,673.8838,216,566,841.97
收到的税费返还5,075,725.594,075,145.253,597,589.32159,371,374.98
收到其他与经营活动有关的现金474,012,168.96243,193,845.25114,960,122741,693,854.55
经营活动现金流入的平衡项目0000
经营活动现金流入小计30,404,991,051.1820,949,301,997.959,778,633,385.239,117,632,071.5
购买商品、接受劳务支付的现金22,133,038,536.2314,862,338,495.137,192,674,623.8228,680,616,058.63
支付给职工以及为职工支付的现金1,827,770,823.051,247,729,927.92651,300,998.762,281,828,435.31
支付的各项税费1,895,562,214.361,315,371,659.24517,357,815.322,262,131,942.27
支付其他与经营活动有关的现金1,959,033,000.431,271,910,545.56683,555,744.842,683,645,602.72
经营活动现金流出的平衡项目0000
经营活动现金流出小计27,815,404,574.0718,697,350,627.859,044,889,182.7435,908,222,038.93
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,589,586,477.112,251,951,370.1733,744,202.463,209,410,032.57
二、投资活动产生的现金流量:
收回投资收到的现金2,408,096,867.72968,704,891.05549,327,186.645,080,545,532.47
取得投资收益收到的现金428,497,195.0516,545,231.65,137,668.34567,196,644.37
处置固定资产、无形资产和其他长期资产收回的现金净额197,342172,44010,0004,079,069.83
处置子公司及其他营业单位收到的现金净额---20,403,838.21
收到的其他与投资活动有关的现金465,645,353.13363,000,0003,000,0001,170,771,170
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,302,436,757.91,348,422,562.65557,474,854.986,842,996,254.88
购建固定资产、无形资产和其他长期资产支付的现金389,382,386.28275,314,995.16135,987,618.23446,732,820.54
投资支付的现金73,700,00068,700,000639,802,094.6711,654,869,186.44
取得子公司及其他营业单位支付的现金---569,283,888.24
支付其他与投资活动有关的现金2,305,272,300697,318,80097,318,800488,193,160.7
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,768,354,686.281,041,333,795.16873,108,512.913,159,079,055.92
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额534,082,071.62307,088,767.49-315,633,657.92-6,316,082,801.04
三、筹资活动产生的现金流量:
吸收投资收到的现金2,670,000--144,736,386.38
其中:子公司吸收少数股东投资收到的现金2,670,000--86,453,260.82
取得借款收到的现金901,453,995.03592,248,791.91235,590,426.422,303,433,120.57
筹资活动现金流入平衡项目0000
筹资活动现金流入小计904,123,995.03592,248,791.91235,590,426.422,448,169,506.95
偿还债务支付的现金1,208,474,903.38917,334,047.3382,032,321.172,238,287,969.2
分配股利、利润或偿付利息支付的现金2,757,260,303.342,741,240,399.439,364,159.782,121,590,675.38
其中:子公司支付给少数股东的股利、利润19,857,165.9611,316,213.63-7,179,781.75
支付其他与筹资活动有关的现金69,527,344.0741,375,308.912,916,955.56821,594,594.84
筹资活动现金流出平衡项目0000
筹资活动现金流出小计4,035,262,550.793,699,949,755.66104,313,436.515,181,473,239.42
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-3,131,138,555.76-3,107,700,963.75131,276,989.91-2,733,303,732.47
四、汇率变动对现金及现金等价物的影响5,005,521.315,239,164.08-5,255,965.7916,271,671.09
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-2,464,485.72-543,421,662.08544,131,568.66-5,823,704,829.85
加:期初现金及现金等价物余额13,046,160,012.4713,046,160,012.4713,046,160,012.4718,869,864,842.32
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额13,043,695,526.7512,502,738,350.3913,590,291,581.1313,046,160,012.47
补充资料:
净利润-2,826,258,821.44-2,840,409,694.19
资产减值准备-55,672,247.39-1,388,893,171.64
固定资产和投资性房地产折旧-105,698,740.66-316,627,661.86
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-105,698,740.66-316,627,661.86
无形资产摊销-15,220,430.41-27,839,854.11
长期待摊费用摊销-14,699,584.4-27,820,395.79
处置固定资产、无形资产和其他长期资产的损失--5,403,078.51--5,944,768.41
固定资产报废损失-2,435,656.06-1,496,772.33
公允价值变动损失--53,088,928.07-619,902,948.31
财务费用-18,798,896.05-67,849,588.22
投资损失--421,542,165.56--868,198,390.16
递延所得税-7,720,302.64--164,293,226.44
其中:递延所得税资产减少-36,123,144.16--198,706,335.8
递延所得税负债增加--28,402,841.52-34,413,109.36
存货的减少-1,078,680,567.88-338,741,897.07
经营性应收项目的减少--274,823,081.61--2,054,964,892.96
经营性应付项目的增加--1,172,171,057.16-1,166,791,741.2
其他----602,704,304.66
现金的期末余额-12,502,738,350.39-13,046,160,012.47
减:现金的期初余额-13,046,160,012.47-18,869,864,842.32
公告日期2023-10-312023-08-302023-04-272023-03-31
审计意见(境内)标准无保留意见
TOP↑